Results for tag: "Integrin Antagonist"

Integrin antagonists are a class of drugs used to treat diseases of the central nervous system (CNS). These drugs target integrins, which are proteins found on the surface of cells that play a role in cell adhesion and migration. By blocking the activity of integrins, integrin antagonists can reduce inflammation and improve the functioning of the CNS. They are used to treat a variety of conditions, including multiple sclerosis, Alzheimer's disease, and Parkinson's disease. Integrin antagonists are a relatively new class of drugs, and their use is still being explored. Clinical trials are ongoing to evaluate their efficacy and safety in treating CNS diseases. Several companies are involved in the development and marketing of integrin antagonists. These include Biogen, Novartis, Merck, and Genentech. Show Less Read more